Cincinnati Children’s Cancer & Blood Diseases Institute is investing $85 million in expanding its clinical and integrated translational research programs in (1) precision medicine & drug discovery, (2) cellular & immune cancer therapy, (3) advanced proton & FLASH therapy, (4) young adult oncology, and (5) next-generation care navigation. Our mission is to use disruptive and innovative team science to cure high-risk and relapsed cancers. We have a culture of collaboration and compassion with stretch goals and ambitious key results. We seek dynamic and outstanding individuals at all faculty levels with a career focus in academic translational research. The Division of Oncology includes 30 academic clinical faculty – with new recruitment positions in our medical subspecialty program